Analyst Ratings for Braveheart Bio (BRVE)
BRVE Rating Summary
BRVE Price Target Summary
- Highest: $48.00 (Goldman Sachs)
- Lowest: $40.00 (Cantor Fitzgerald)
- Average: $45.25
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$45.25 (+68.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$45.25 (+68.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/31/2026 | Cantor Fitzgerald | Olivia Brayer Saunders | New Coverage | Overweight (N/A) |
40.00 (N/A) |
27.44 (26.80) |
-2.33% | Details |
| 8/31/2026 | TD Cowen | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
27.44 (26.80) |
-2.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
